Jay M. Moyes, Chief Financial Officer at MYRIAD GENETICS INC (MYGN), sold 8,156 shares at $32.50 ($265K) on 2007-01-09, disclosed to the SEC on 2007-01-11.
Scheduled sale ($265k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $32.50 | 712 | $23K | 8.7% |
| 2 | $32.50 | 7,444 | $242K | 91.3% |
| Total | $32.50 avg | 8,156 | $265K | 100% |
| Filing → |
| SINT | BUY | 2025-08-27 | $11K | — | Filing → |
| PBYI | SELL | 2025-06-17 | $75K | — | Filing → |
| PBYI | SELL | 2024-06-17 | $73K | — | Filing → |